Dr. Anna Melkonyan, DO

Dr. Melkonyan practices at UCLA Medical Plaza in Los Angeles, California.

Dr. Melkonyan's NPI, 1891340816, was assigned on August 6, 2019. Dr. Melkonyan graduated from WesternU College of Osteopathic Medicine of the Pacific in 2019. Dr. Melkonyan holds California license 20A19708.

Dr. Melkonyan's primary practice is UCLA Medical Plaza, at 5767 W Century Blvd, Los Angeles, CA 90045 in Los Angeles County. The practice phone is (310) 794-1276.

Dr. Melkonyan's primary practice is UCLA Medical Plaza in Los Angeles, California. Dr. Melkonyan is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Melkonyan to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melkonyan practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Melkonyan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Melkonyan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Melkonyan is licensed in California.

Dmand AI lists acute gastroduodenitis, acute skin infection, aneurysm, aortic atherosclerois, asthma, cerebrovascular disease, chronic anemia and chronic diabetes among the conditions Dr. Melkonyan treats.

CMS data shows 1,448 Medicare services from Dr. Melkonyan across 17 procedure codes in 2024, for 417 Medicare patients. Medicare paid $93,571 for them. Every service was in an office.

CMS counts 417 Medicare patients who saw Dr. Melkonyan in 2024. The largest group is 65 to 74, with 205 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Melkonyan's median patient age at 58, with 70% women.

In 2024, Dr. Melkonyan wrote 3,523 Medicare Part D claims for 476 patients. 88% of them were for generic drugs. CMS names the drug for 2,936 of them, across 70 drugs with 11 or more claims each, at $232,814 in total drug cost. In 2023, CMS named 1,320 claims across 49 drugs.

Dr. Melkonyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Melkonyan as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Melkonyan from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $197.

Dr. Melkonyan graduated from WesternU College of Osteopathic Medicine of the Pacific in 2019.

Dr. Melkonyan is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.